摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-diazo-4H-imidazol-5-carbonitril | 53000-41-2

中文名称
——
中文别名
——
英文名称
4-diazo-4H-imidazol-5-carbonitril
英文别名
4-diazo-4H-imidazole-5-carbonitrile;5-diazo-5H-imidazole-4-carbonitrile;(5Z)-5-diazoimidazole-4-carbonitrile
4-diazo-4H-imidazol-5-carbonitril化学式
CAS
53000-41-2
化学式
C4HN5
mdl
——
分子量
119.085
InChiKey
PDSXUDBYKBJDTK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    50.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    4-diazo-4H-imidazol-5-carbonitril一水合肼 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以46%的产率得到5(4)-azidoimidazole-4(5)-carbonitrile
    参考文献:
    名称:
    Synthesis and properties of analogs of 5(or 4)-aminoimidazole-4(or 5)-carboxamide (aica) and purines. 12. Investigation of the interaction of 4-chloroimidazo[4,5-d]-1,2,3-triazine with nucleophiles
    摘要:
    DOI:
    10.1007/bf00515366
  • 作为产物:
    描述:
    5-氨基-1H-咪唑-4-甲腈盐酸盐 在 盐酸 、 sodium nitrite 作用下, 以 为溶剂, 反应 0.75h, 生成 4-diazo-4H-imidazol-5-carbonitril
    参考文献:
    名称:
    Andersen, Knud Erik; Pedersen, Erik B., Liebigs Annalen der Chemie, 1986, # 6, p. 1012 - 1020
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Antitumor Imidazotetrazines. 35. New Synthetic Routes to the Antitumor Drug Temozolomide
    作者:Yongfeng Wang、Malcolm F. G. Stevens、Tze-ming Chan、Donald DiBenedetto、Zhe-xing Ding、Dinesh Gala、Donald Hou、Max Kugelman、William Leong、Shen-chun Kuo、Janet L. Mas、Doris P. Schumacher、Bruce P. Shutts、Lyman Smith、Zheng-Yun J. Zhan、William T. Thomson
    DOI:10.1021/jo970802l
    日期:1997.10.1
    Three new pathways to the antitumor drug temozolomide (4) have been explored via intermediates 3, 6, and 7. The key intermediate 5-amino-1-(N-methylcarbamoyl)imidazole-4-carboxamide (6) has been successfully converted to 4 in 45% yield by employing sodium nitrite in aqueous tartaric acid at 0-5 degrees C, Compound 6 is prepared from nitrophenyl carbamate 14a and methylamine or directly from 5-aminoimidazole-4-carboxamide (13) and either methyl isocyanate or N-methylcarbamoyl chloride. Temozolomide (4) is also prepared from 8-cyano-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (7) by hydrolysis to the hydrochloride salt of 4 in 10 M hydrochloric acid. Compound 7 is prepared from either 5-diazoimidazole-4-carbonitrile (28) and methyl isocyanate or by diazotization of 5-amino-1-(N-methylcarbamoyl)imidazole-4-carbonitrile (25). Attempts to cyclize 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (3) with phosgene or phosgene equivalents were unsuccessful: only 2-azahypoxanthine (11) was isolated.
  • Antitumor imidazotetrazines. 14. Synthesis and antitumor activity of 6- and 8-substituted imidazo[5,1-d]-1,2,3,5-tetrazinones and 8-substituted pyrazolo[5,1-d]-1,2,3,5-tetrazinones
    作者:Edward Lunt、Christopher G. Newton、Christopher Smith、Graham P. Stevens、Malcolm F. G. Stevens、Colin G. Straw、Roger J. A. Walsh、Peter J. Warren、Christian Fizames
    DOI:10.1021/jm00385a018
    日期:1987.2
    The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at positions 6 and 8 and to change the imidazo[5,1-d]-1,2,3,5-tetrazinone (1) skeleton to the isomeric pyrazolo-[5,1-d]-1,2,3,5-tetrazinone (17) skeleton. The series of eight 6-alkyl and 6-aralkyl derivatives of 1 showed optimal antitumor activity when the group was small or linear, but activity diminished as size and branching of this substituent increased. This may reflect altered transport characteristics, or failure of the enlarged derivatives to fit a binding site, or possibly a reduced tendency for the derivatives having bulky groups at position 6 to hydrolytically generate the putatively active triazenes (21). Testing of 14 derivatives of 1 differently substituted at position 8 revealed a complex structure-activity relationship, with good antitumor activity obtained for carbamoyl and sulfamoyl groups bearing small substituents. The 8-methylsulfonyl compound had noteworthy activity, but the 8-cyano, 8-nitro, and 8-phenyl derivatives were devoid of useful antitumor activity in these tests. From the limited number of pyrazolotetrazinones (17) reported here, it is suggested that the same conclusions as regards activity also hold true for this ring system.
  • Synthesis and properties of analogs of 5(4)-aminoimidazole-4(5)-carboxamide and purines. 15. Ring opening in imidazo[4,5-d]-1,2,3-triazines
    作者:V. K. Usova、I. S. Selezneva、T. A. Pospelova、V. S. Mokrushin
    DOI:10.1007/bf00487307
    日期:1989.9
  • Baig, Ghouse Unissa; Stevens, Malcolm F. G.; Stone, Robert, Journal of the Chemical Society. Perkin transactions I, 1982, # 8, p. 1811 - 1820
    作者:Baig, Ghouse Unissa、Stevens, Malcolm F. G.、Stone, Robert
    DOI:——
    日期:——
  • Synthesis of 6,8-substituted derivatives of imidazo[5,1-c][1,2,4]triazines and 1,4-dihydroimidazo[5,1-c][1,2,4]triazin-4-ones
    作者:M. A. Bezmaternykh、V. S. Mokrushin、T. A. Pospelova、O. S. El'tsov
    DOI:10.1007/bf02252280
    日期:1998.6
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺